FDA 483 OBSERVATION · #9 OF 1,945 MOST-CITED

Manufacturing, processing, packing, holding - Controls

FDA cited this observation 1,419 times across 1,265 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods1,419
BY FISCAL YEAR
FY20272
FY2026170
FY2025190
FY2024184
FY2023143
FY2022153
FY202187
FY202093
FY2019170
FY2018174
FY201753

What this observation means, and how to comply

SPEQ's practitioner reading of this finding. The regulatory basis is a cited fact; the interpretation, compliance steps, and root causes are SPEQ synthesis — not an FDA classification of the citation.

21 CFR 117 Subpart B (food) · 21 CFR 211 Subpart F (drugs)

The controls over manufacturing, processing, packing, and holding operations were inadequate to prevent contamination or ensure the product is safe and made under controlled conditions — covering process controls, sanitation during production, and protection of product.

Why FDA writes it — These are the core in-process controls that keep product safe and consistent as it is made and held. Weak controls at this stage let contamination, mix-ups, or process failures reach the product directly, which is why it is a high-frequency, high-consequence finding in food operations especially.

HOW TO COMPLY
  • Conduct manufacturing, processing, packing, and holding operations under conditions and controls that prevent contamination and adulteration.
  • Control the process parameters that matter for safety and quality, and monitor them at an adequate frequency.
  • Protect product, food-contact surfaces, and packaging from contamination throughout the operation.
  • Document the controls and any corrective actions when conditions go out of control.
WHY FIRMS GET CITED
  • Process controls defined on paper but not monitored at an adequate frequency during actual production.
  • Product left inadequately protected during holding or transfer steps between controlled operations.
PROFESSIONAL · REMEDIATION PLAYBOOK · SPEQ SYNTHESIS

How to close this finding — and stop it recurring

CHECKING ACCESS

Checking your access…

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 0.9× the rate of the average FDA-cited firm (7.0% vs 7.8%), across 1,265 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

You did not conduct operations under conditions and controls necessary to minimize the potential for growth or survival of microorganisms, allergen cross-contact and contamination of food.

BIANCO FINE FOODS LLC · Miami, Florida · Foods · 2026-10-23

You did not conduct operations under conditions and controls necessary to minimize the potential for growth or survival of microorganisms, contamination of food and deterioration of food.

Tam An 2, Inc. (formerly Rach Gia, Inc.) · Westminster, California · Foods · 2026-10-07

You did not conduct operations under conditions and controls necessary to minimize the potential for contamination of food.

Kingston Cheese Cooperative · Cambria, Wisconsin · Foods · 2026-09-24

You did not conduct operations under conditions and controls necessary to minimize the potential for growth or survival of microorganisms and deterioration of food.

The H.T. Hackney Company · Indianapolis, Indiana · Foods · 2026-09-23

You did not conduct operations under conditions and controls necessary to minimize the potential for growth or survival of microorganisms.

Potato Products of Idaho LLC · Rigby, Idaho · Foods · 2026-09-18

You did not conduct operations under conditions and controls necessary to minimize the potential for allergen cross-contact.

Digestive Diet, Inc. · Monsey, New York · Foods · 2026-09-17

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Food industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →